Doseology Sciences Inc. Canada British Columbia Ontario

(2)

Consumers are increasingly seeking portable, clean, crash-free formats for focus, alertness, and productivity; especially, among working professionals, athletes, military personnel, and high-output individuals.

Pouches offer a convenient, sugar-free alternative to traditional beverages—perfectly aligned with modern performance lifestyles.

Source 1: (https://www.grandviewresearch.com/industry-analysis/energy-drinks-market)
Source 2: (https://www.grandviewresearch.com/industry-analysis/nicotine-pouches-market-report).

About Joseph Mimran & Associates Inc.

Joseph Mimran is a Canadian designer, entrepreneur, and retail visionary with a 40+ year track record of building billion-dollar consumer brands. He co-founded the Alfred Sung brand and founded Club Monaco, later acquired by Ralph Lauren. He is also the founder of Joe Fresh, one of Canada's most successful apparel brands.

Through his firm, Joseph Mimran & Associates, he advises high-growth companies on design, retail strategy, and brand development. He is the owner of Tilley Endurables, Gry Mattr, Rise Little Earthling, and Coco Village, as well as the majority shareholder of Mastermind Toys and Kit and Ace. His work spans apparel, home, lifestyle, and toy categories, with a unique ability to combine creative vision and disciplined execution.

Mimran's career also includes serving as a Dragon on CBC's Dragons' Den from 2015 to 2018, where he championed Canadian entrepreneurship.

About Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70)

Doseology is a biotech innovation company, engineering precision?formulated oral stimulants that optimize energy, focus, and cognitive performance. Through rigorous scientific research and advanced delivery technologies, we're pioneering next?gen performance solutions designed to empower peak performance.

On behalf of the Board of Directors, Chris Jackson
CEO
Doseology Sciences Inc.

For more information, please contact the Company at:
Email: hello@doseology.com
Website: www.doseology.com
Phone: 604.908.3095

Forward Looking Statements

This press release contains statements that constitute "forward?looking information" within the meaning of applicable securities laws. Forward?looking information is often identified by the words "may," "would," "could," "should," "will," "intend," "plan," "anticipate," "believe," "estimate," "expect" or similar expressions. Readers are cautioned that forward?looking information is not based on historical facts but instead reflects the Company's management's expectations, estimates or projections concerning the business of the Company's future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward?looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance, or achievements. Among the key factors that could cause actual results to differ materially from those projected in the forward?looking information are the following: changes in general economic, business and political conditions, including changes in the financial markets; decreases in the prevailing prices for products in the markets that the Company operates in; adverse changes in applicable laws or adverse changes in the application or enforcement of current laws; regulations and enforcement priorities of governmental authorities; compliance with government regulation and related costs; and other risks described in the Company's prospectus. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward?looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated, or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward?looking information except as otherwise required by applicable law. For more information, investors should review the Company's filings which are available on SEDAR+.

No securities regulatory authority has either approved or disapproved of the contents of this press release. The Company's securities have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, or any state securities laws, and may not be offered or sold in the United States, or to or for the account or benefit of any person in the United States, absent registration, or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities in the United States, or in any other jurisdiction in which such offer, solicitation or sale would be unlawful. The CSE does not accept responsibility for the adequacy or accuracy of this release.

Logo: https://mma.prnewswire.com/media/2753081/Doseology_Sciences_Inc_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/doseology-acquires-feed-that-brain-and-appoints-joseph-mimran-as-strategic-advisor-302533196.html